Introduction
Sweet's syndrome, or acute febrile neutrophilic dermatosis, is an infrequent skin disease characterized by sudden onset of fever, leukocytosis, tender erythematous plaques or nodules, and diffuse infiltrate consisting predominantly of mature neutrophils that are typically located in the upper dermis without vasculitis. 1, 2) Sweet's syndrome is associated with many conditions including cancer, infections, inflammatory bowel disease, drugs, pregnancy, and autoimmune connective tissue diseases. 1, 3) Sweet's syndrome can also occur in patients with Hashimoto's thyroiditis, [4] [5] [6] and rarely in patients with Graves' disease, in which all reported cases were caused by use of propylthiouracil (PTU). [7] [8] [9] Extracutaneous manifestations of Sweet's syndrome can present in the ocular mucosa and mouth, as well as in the bone, central nervous system, kidneys, intestines, liver, heart, lungs, muscles, and spleen. 1, 8) Here we report a case of Sweet's syndrome associated with Graves' disease per se but not a drug use.
Case Report
A 34-year-old man was referred for typical thyrotoxic symptoms and signs, diffuse goiter, and ophthalmopathy. He had heat intolerance and sweating, palpitations, 20 kg weight loss despite increased appetite and oral intake, and hand tremor during about four months. His pulse rate was 140 beats/minute with sinus rhythm and his thyroid was diffusely enlarged to Sweet's syndrome is an acute febrile neutrophilic dermatosis which is characterized by painful papules and nodules, fever, elevated neutrophil count and ESR, and infiltration of neutrophils into the dermis. were observed in Sweet's syndrome patient serum.
1)
Increased levels of G-CSF can explain leukocytosis, neutrophilic dermatosis and skin lesions, while increased levels of IL-6 are thought to be associated with fever and pain. Graves' disease is uncommon. Only three cases have been reported in the literature, two reports by PTU and one report by G-CSF. [7] [8] [9] The first case was a 37-year-old woman who had been diagnosed with Graves' disease three years ago. 7) She was treated with PTU without any problems for the first two years.
PTU had been recommended at a dose 100 mg three times daily for three months before the presentation with Sweet's syndrome. She had no other medical or medication history. 7) The second case was a 33-year-old woman treated with PTU for 13 months.
9)
The last case was a 43-year-old woman who developed fever and pancytopenia as an adverse effect of PTU after the treatment with PTU 300 mg daily for three weeks. 8) She was treated with G-CSF for agranulocytosis and developed Sweet's syndrome by G-CSF use. ANCA was positive after using PTU in all three cases, suggesting a pathogenic role of PTU-induced ANCA in Sweet's syndrome. [7] [8] [9] The present patient developed fever, skin rash, arthralgia, acroparesthesia after initiation of MMI and be- Sweet's syndrome are potentially able to affect thyroid gland. 6, 13) In conclusion, clinicians should be aware of very rare associations with Sweet's syndrome and autoimmune thyroid disease, including Graves' disease or rare adverse effects of PTU but not MMI. Our case suggests an expanded differential diagnosis for fever and skin rash in patients with underlying Graves' disease.
